We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




News Implants for Spinal Surgery

By HospiMedica staff writers
Posted on 25 Oct 2005
A novel bone insert and a vertebral-body replacement were introduced at the annual meeting of the North American Spine Society in Seattle (WA, USA) in September 2005.

The Xpanse bone insert incorporates the proprietary demineralized bone fiber technology and demineralized cancellous chips of Osteotech, Inc. More...
(Eatontown, NJ, USA) to provide a tissue graft that is osteoinductive, osteoconductive, and osteoconforming. This bone insert expands up to 10 mm when rehydrated in vivo, providing more complete bone surface contact during orthopedic and reconstructive applications.

The GraftCage TLX is a vertebral-body replacement device designed for strength and ease of insertion. It can be implanted by utilizing existing Osteotech instrumentation for transverse spinal interbody procedures. A large opening for the insertion of fusion-enhancing materials allows for maximum graft exposure. Three titanium markers facilitate intraoperative and postoperative radiographic assessments.

"We sized the Xpanse bone insert to fit within the GraftCage TLX; however, it can be utilized alone or with other spinal implants where allograft or autograft bone would be used,” explained Sam Owusu-Akyaw, president and CEO of Osteotech. "Used together, the Xpanse bone insert and the GraftCage TLX create a unique vertebral-body spacer, allowing for maximum endplate contact, structural support, osteoinductivity and osteoconductivity, which are the four key components of a successful fusion.”




Related Links:
Osteotech

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.